These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30196444)

  • 41. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Hereditary Hemochromatosis Gene H63D and C282Y Mutations on Iron Overload in Sickle Cell Disease Patients.
    Terzi YK; Bulakbaşı Balcı T; Boğa C; Koç Z; Yılmaz Çelik Z; Özdoğu H; Karakuş S; Şahin Fİ
    Turk J Haematol; 2016 Dec; 33(4):320-325. PubMed ID: 27095682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry.
    Mohd Ibrahim H; Muda Z; Othman IS; Mohamed Unni MN; Teh KH; Thevarajah A; Gunasagaran K; Ong GB; Yeoh SL; Muhammad Rivai A; Che Mohd Razali CH; Din ND; Abdul Latiff Z; Jamal R; Mohamad N; Mohd Ariffin H; Alias H
    BMJ Open; 2020 Jun; 10(6):e037974. PubMed ID: 32601117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention.
    Aydınok Y; Oymak Y; Atabay B; Aydoğan G; Yeşilipek A; Ünal S; Kılınç Y; Oflaz B; Akın M; Vergin C; Sezgin Evim M; Çalışkan Ü; Ünal Ş; Bay A; Kazancı E; İleri T; Atay D; Patıroğlu T; Kahraman S; Söker M; Akcan M; Akdeniz A; Büyükavcı M; Alanoğlu G; Bör Ö; Soyer N; Özdemir Karadaş N; Uysalol E; Türker M; Akçay A; Ocak S; Güneş AM; Tokgöz H; Ünal E; Tiftik N; Karakaş Z
    Turk J Haematol; 2018 Mar; 35(1):12-18. PubMed ID: 28404539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
    Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.
    Roghi A; Cappellini MD; Wood JC; Musallam KM; Patrizia P; Fasulo MR; Cesaretti C; Taher AT
    Ann Hematol; 2010 Jun; 89(6):585-9. PubMed ID: 20016898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
    Ricchi P; Meloni A; Pistoia L; Spasiano A; Spiga A; Allò M; Gamberini MR; Lisi R; Campisi S; Peluso A; Missere M; Renne S; Mangione M; Positano V; Pepe A
    Ann Hematol; 2018 Oct; 97(10):1925-1932. PubMed ID: 29926157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes in Patients with ß-thalassemia or other Hemoglobinopathies - Analysis from the DPV Database.
    Warncke K; Konrad K; Kohne E; Hammer E; Ohlenschläger U; Herrlinger S; Jäger A; Holl RW
    Klin Padiatr; 2016 Nov; 228(6-07):307-312. PubMed ID: 27846660
    [No Abstract]   [Full Text] [Related]  

  • 51. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
    Rodriguez-Capote K; Higgins TN
    Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of hemoglobinopathies in Oman through a national register.
    Rajab AG; Patton MA; Modell B
    Saudi Med J; 2000 Dec; 21(12):1168-72. PubMed ID: 11360093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).
    Paulukonis ST; Harris WT; Coates TD; Neumayr L; Treadwell M; Vichinsky E; Feuchtbaum LB
    Pediatr Blood Cancer; 2014 Dec; 61(12):2271-6. PubMed ID: 25176145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia.
    Musallam KM; Cappellini MD; Taher AT
    Blood Cells Mol Dis; 2013 Jun; 51(1):35-8. PubMed ID: 23425967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
    Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
    Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA; Nzouakou R; Ameen V; Sirigireddy B; Amos RJ
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Liver and heart iron deposition status in patients with β thalassemia major: a multicenter study].
    Li C; Liu S; Wang Y; Wen F; Gao H; Chen G; Li C; Wu X; Fang J; Hao W; Liu R; Zhang X; Chu CW; Au W
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):90-3. PubMed ID: 24739717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver iron overload assessment by T *2 magnetic resonance imaging in pediatric patients: an accuracy and reproducibility study.
    Cheng HL; Holowka S; Moineddin R; Odame I
    Am J Hematol; 2012 Apr; 87(4):435-7. PubMed ID: 22286974
    [No Abstract]   [Full Text] [Related]  

  • 59. Iron overload and malignancies in patients with haemoglobinopathies: A single center experience.
    Rigoli L; Petrungaro A; Di Bella C; Caruso R
    Transfus Apher Sci; 2019 Oct; 58(5):647-651. PubMed ID: 31519524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.